Jubilant draws FDA rebuke for delayed mold investigation and quality unit lapses
Jubilant HollisterStier received a warning letter over problems that the FDA said necessitate an immediate and comprehensive assessment of the contract manufacturing organization’s global operations.
Read the full article on the original site.
Read Full Article